CPHI Frankfurt 2025 Set To Welcome 63,000+ Pharma Professionals With Expanded Innovation Zones And Record-Breaking Programme

Informa Markets will once again host the global pharmaceutical industry at CPHI Frankfurt 2025, scheduled for October 28–30 at Messe Frankfurt. The three-day exhibition is set to attract over 63,000 attendees, featuring six content theatres, more than 2,000 exhibitors, and a full programme focused on networking and innovation.

“CPHI is more than an event, it’s a global experience. It’s the one place each year where the full pharmaceutical supply chain comes together to collaborate, build relationships, and get business done,” said Tara Dougal, event director, CPHI Frankfurt. 

Marking its 36th edition, CPHI Frankfurt continues to be the world’s largest and most influential pharmaceutical event, uniting professionals from across the drug development and manufacturing value chain. The event is organised by Informa Markets, a division of Informa PLC, which delivers leading B2B events worldwide.

“The new zones are designed to keep pace with where the market is going. They’re a direct response to rising demand from both attendees and exhibitors for more focused, future-looking areas within the show,” said Dougal. 

After a record-breaking 2024 edition in Milan, which welcomed 59,000 attendees, this year’s event is expected to set a new benchmark. In line with industry diversification, CPHI has expanded in recent years to include bioproduction, finished dosage formulation, drug delivery, and packaging, alongside its core strength in APIs.

“Whether you're a first-time attendee or a returning exhibitor, planning is key. Our digital platform helps attendees get the most value by pre-booking meetings, building agendas, and navigating efficiently on site,” Dougal said. 

For 2025, the event will introduce new feature zones designed to support innovation, diversification, and stronger sector engagement. These will highlight key areas such as digital health technologies, AI-driven drug development, and sustainable pharmaceutical manufacturing, reflecting the industry’s shifting priorities and offering new opportunities for participants.

Attendees can also access a robust line-up of features that enhance both business outcomes and professional development:

●     Six content theatres, running across all three days, offering insight into market trends, R&D, manufacturing, and regulation.

●     The CPHI Awards and Celebration, recognising innovation and leadership across 14 categories, including Women in Pharma and Future Leader of the Year.

●     Happy hour networking events on days one and two, designed to foster informal connections.

●     An event planner app with agenda-building and real-time floor navigation features, remaining active post-show to support follow-up.

The CPHI global portfolio now includes 10 international events across Europe, the Americas, the Middle East, and Asia. The latest addition, CPHI Middle East, launched in Riyadh in 2024 and is set to return in April 2026.